Ledger.Open graph →
SEC Form D · Amendment · filed March 12, 2021

Paragon Biosciences Emalex Capital, Inc

Offering
$35.0M
Sold
$35.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORTHBROOK, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Kevin Chavers · New York, NYDirectorAl C. Laskaj · NEW YORK, NYDirectorAmit Assaraf · New York, NYExecWilliam D. Rahm · New York, NYExec · DirectorJeffrey J. Aronin · Chicago, ILDirectorRicardo Lombardi · New York, NYDirectorDarien J. Parhad · Chicago, ILExecDana C. Devivo · NEW YORK, NYExecAntonio J. Gracias · Chicago, ILDirectorPatrick J. Morris · Chicago, ILExec · DirectorFrancis C. Poli · NEW YORK, NYExec · DirectorPatrick N. Nolan · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗